Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed director
Quarterly results
Director departure
|
|
ACHILLION PHARMACEUTICALS INC (ACHN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/19/2019 |
GN
| Achillion Shareholders Approve Agreement to be Acquired by Alexion |
| 12/09/2019 |
GN
| Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American Society of Hematology Meeting |
| 11/29/2019 |
GN
| Rigrodsky & Long, P.A. Files Class Action Suit Against Achillion Pharmaceuticals, Inc. |
| 11/19/2019 |
GN
| European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Not Adequately Responding to a C5 Inhibitor |
| 11/11/2019 |
GN
| Achillion Announces Clearance of Investigational New Drug Application for ACH-5228 |
| 11/07/2019 |
GN
| Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update |
| 11/06/2019 |
GN
| Achillion Announces Data Presentations at the 61st American Society of Hematology Annual Meeting |
| 11/04/2019 |
GN
| Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – LPT, CISN, IPHS, ACHN |
| 10/29/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations |
| 10/23/2019 |
GN
| MERGER ALERT – ACHN, JAG, and ROAN: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies |
| 09/26/2019 |
GN
| Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference |
| 09/25/2019 |
GN
| Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria |
| 08/29/2019 |
GN
| Achillion to Present at the Baird 2019 Global Healthcare Conference |
| 06/13/2019 |
GN
| Achillion to Present at the JMP Securities Life Sciences Conference |
| 06/10/2019 |
GN
| Achillion Announces Upcoming Scientific Presentation at the 24th Congress of the European Hematology Association |
| 05/17/2019 |
GN
| Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting |
| 05/14/2019 |
GN
| Achillion Granted Twentieth Patent for Factor D Portfolio |
| 05/09/2019 |
GN
| Achillion Reports First Quarter 2019 Financial Results |
| 04/03/2019 |
GN
| Achillion Announces Enrollment Milestone in Phase 2 Trials for C3 Glomerulopathy |
| 03/27/2019 |
GN
| Achillion Announces Completion of Enrollment in Phase 2 PNH Combination Trial |
| 03/08/2019 |
GN
| Achillion to Present at the Barclays Global Healthcare Conference |
| 03/07/2019 |
GN
| Achillion Reports Fourth Quarter and Full Year 2018 Financial Results |
| 02/21/2019 |
GN
| Achillion Pharmaceuticals Expands Operations and Clinical Development into Philadelphia Area Office Market |
| 02/19/2019 |
GN
| Achillion to Present at the SVB Leerink 8th Annual Global Healthcare Conference |
| 02/11/2019 |
GN
| Achillion Appoints Brian Di Donato as Chief Financial Officer |
| 01/03/2019 |
GN
| Achillion Announces Nicole Vitullo Elected to Chair the Board of Directors |
| 12/17/2018 |
GN
| Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Trials and Provides Clinical Development Strategy Update |
| 12/10/2018 |
GN
| Achillion Interim Clinical Trial Data and Strategic Update Planned for Dec 17th, 2018 |
| 11/07/2018 |
GN
| Achillion Reports Third Quarter 2018 Financial Results |
| 10/17/2018 |
GN
| Investor Expectations to Drive Momentum within SunOpta, Acorda Therapeutics, Sapiens International Corporation N.V, The Descartes Systems Group, Achillion Pharmaceuticals, and CSS Industries — Discovering Underlying Factors of Influence |
| 09/25/2018 |
GN
| Achillion to Present at the Leerink Partners Roundtable Series |
| 09/10/2018 |
GN
| Achillion Appoints Paul Firuta Chief Operating Officer |
| 08/30/2018 |
GN
| Achillion to Present at the Baird 2018 Global Healthcare Conference |
| 08/21/2018 |
GN
| Achillion Appoints Dr. Steven Zelenkofske as Chief Medical Officer and Further Strengthens Clinical Development Team |
|
|
|